{"id":"https://openalex.org/W1982966729","doi":"https://doi.org/10.1089/dia.2012.0105","title":"The Emergence of Biosimilar Insulin Preparations\u2014A Cause for Concern?","display_name":"The Emergence of Biosimilar Insulin Preparations\u2014A Cause for Concern?","publication_year":2012,"publication_date":"2012-10-09","ids":{"openalex":"https://openalex.org/W1982966729","doi":"https://doi.org/10.1089/dia.2012.0105","mag":"1982966729","pmid":"https://pubmed.ncbi.nlm.nih.gov/23046400","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/3698679"},"language":"en","primary_location":{"id":"doi:10.1089/dia.2012.0105","doi":"https://doi.org/10.1089/dia.2012.0105","is_oa":true,"landing_page_url":"https://doi.org/10.1089/dia.2012.0105","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology & Therapeutics","raw_type":"journal-article"},"volume":null,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1089/dia.2012.0105","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5078134786","display_name":"David R. Owens","orcid":"https://orcid.org/0000-0003-1002-1238","observed_orcids":["https://orcid.org/0000-0003-1002-1238"]},"institutions":[{"id":"https://openalex.org/I79510175","display_name":"Cardiff University","ror":"https://ror.org/03kk7td41","country_code":"GB","type":"education","lineage":["https://openalex.org/I79510175"]}],"countries":["GB"],"is_corresponding":true,"raw_author_name":"David R. Owens","raw_affiliation_strings":["Cardiff University","Institute of Molecular and Experimental Medicine, Cardiff University, Wales, United Kingdom"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cardiff University","institution_ids":["https://openalex.org/I79510175"]},{"raw_affiliation_string":"Institute of Molecular and Experimental Medicine, Cardiff University, Wales, United Kingdom","institution_ids":["https://openalex.org/I79510175"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058274800","display_name":"Wolfgang Landgraf","orcid":"https://orcid.org/0000-0001-5321-7164","observed_orcids":["https://orcid.org/0000-0001-5321-7164"]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]},{"id":"https://openalex.org/I4210162051","display_name":"University Hospital Carl Gustav Carus","ror":"https://ror.org/04za5zm41","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210162051"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Wolfgang Landgraf","raw_affiliation_strings":["Carl-Gustav-Carus University","sanofi-aventis, Frankfurt, Germany","Third Medical Department, Carl-Gustav-Carus University, Dresden, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Carl-Gustav-Carus University","institution_ids":[]},{"raw_affiliation_string":"sanofi-aventis, Frankfurt, Germany","institution_ids":["https://openalex.org/I4210138838"]},{"raw_affiliation_string":"Third Medical Department, Carl-Gustav-Carus University, Dresden, Germany","institution_ids":["https://openalex.org/I4210162051"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Andrea Schmidt","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210138838","display_name":"Sanofi (Germany)","ror":"https://ror.org/03ytdtb31","country_code":"DE","type":"company","lineage":["https://openalex.org/I3018075036","https://openalex.org/I4210138838"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andrea Schmidt","raw_affiliation_strings":["sanofi-aventis, Frankfurt, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"sanofi-aventis, Frankfurt, Germany","institution_ids":["https://openalex.org/I4210138838"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111662480","display_name":"Reinhard G. Bretzel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I200763008","display_name":"Justus-Liebig-Universit\u00e4t Gie\u00dfen","ror":"https://ror.org/033eqas34","country_code":"DE","type":"education","lineage":["https://openalex.org/I200763008"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Reinhard G. Bretzel","raw_affiliation_strings":["Justus-Liebig-University Giessen","Justus-Liebig-University Giessen, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Justus-Liebig-University Giessen","institution_ids":["https://openalex.org/I200763008"]},{"raw_affiliation_string":"Justus-Liebig-University Giessen, Germany","institution_ids":["https://openalex.org/I200763008"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5059390484","display_name":"Martin K. Kuhlmann","orcid":"https://orcid.org/0000-0002-6439-8412","observed_orcids":["https://orcid.org/0000-0002-6439-8412"]},"institutions":[{"id":"https://openalex.org/I4210152015","display_name":"Klinikum im Friedrichshain","ror":"https://ror.org/03zzvtn22","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210152015"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Martin K. Kuhlmann","raw_affiliation_strings":["Vivantes Klinikum im Friedrichshain","Division of Nephrology, Vivantes Klinikum im Friedrichshain, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vivantes Klinikum im Friedrichshain","institution_ids":["https://openalex.org/I4210152015"]},{"raw_affiliation_string":"Division of Nephrology, Vivantes Klinikum im Friedrichshain, Berlin, Germany","institution_ids":["https://openalex.org/I4210152015"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5078134786"],"corresponding_institution_ids":["https://openalex.org/I79510175"],"apc_list":null,"apc_paid":null,"fwci":0.7382,"has_fulltext":false,"cited_by_count":67,"citation_normalized_percentile":{"value":0.61357702,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"14","issue":"11","first_page":"989","last_page":"996"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11792","display_name":"Pharmaceutical Economics and Policy","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13417","display_name":"Biomedical Ethics and Regulation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2910","display_name":"Issues, ethics and legal aspects"},"field":{"id":"https://openalex.org/fields/29","display_name":"Nursing"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.9599999785423279},{"id":"https://openalex.org/keywords/insulin","display_name":"insulin","score":0.8389999866485596},{"id":"https://openalex.org/keywords/insulin-analogs","display_name":"insulin analogues","score":0.996999979019165},{"id":"https://openalex.org/keywords/patent-expiration","display_name":"patent expiry","score":0.5699999928474426},{"id":"https://openalex.org/keywords/biosimilar-approval","display_name":"biosimilar approval","score":0.6370000243186951},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.9879999756813049},{"id":"https://openalex.org/keywords/batch-to-batch-consistency","display_name":"batch-to-batch consistency","score":0.8889999985694885},{"id":"https://openalex.org/keywords/product-stability","display_name":"product stability","score":0.6949999928474426},{"id":"https://openalex.org/keywords/regulatory-harmonization","display_name":"regulatory harmonization","score":0.4690000116825104},{"id":"https://openalex.org/keywords/post-marketing-surveillance","display_name":"post-marketing surveillance","score":0.5849999785423279}],"concepts":[{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.985917329788208},{"id":"https://openalex.org/C2776473838","wikidata":"https://www.wikidata.org/wiki/Q174165","display_name":"Innovator","level":3,"score":0.9010598063468933},{"id":"https://openalex.org/C57658597","wikidata":"https://www.wikidata.org/wiki/Q1550789","display_name":"Pharmacovigilance","level":3,"score":0.7388474345207214},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.717847466468811},{"id":"https://openalex.org/C112930515","wikidata":"https://www.wikidata.org/wiki/Q4389547","display_name":"Risk analysis (engineering)","level":1,"score":0.539225161075592},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.5291498303413391},{"id":"https://openalex.org/C3019948211","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Human insulin","level":3,"score":0.5242909789085388},{"id":"https://openalex.org/C2776664568","wikidata":"https://www.wikidata.org/wiki/Q742283","display_name":"Insulin analog","level":4,"score":0.46555760502815247},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39911043643951416},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.34774625301361084},{"id":"https://openalex.org/C144133560","wikidata":"https://www.wikidata.org/wiki/Q4830453","display_name":"Business","level":0,"score":0.28586214780807495},{"id":"https://openalex.org/C10138342","wikidata":"https://www.wikidata.org/wiki/Q43015","display_name":"Finance","level":1,"score":0.08279943466186523},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.0},{"id":"https://openalex.org/C84309077","wikidata":"https://www.wikidata.org/wiki/Q3908516","display_name":"Entrepreneurship","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007328","descriptor_name":"Insulin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013810","descriptor_name":"Therapeutic Equivalency","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":false},{"descriptor_ui":"D059451","descriptor_name":"Biosimilar Pharmaceuticals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true}],"locations_count":5,"locations":[{"id":"doi:10.1089/dia.2012.0105","doi":"https://doi.org/10.1089/dia.2012.0105","is_oa":true,"landing_page_url":"https://doi.org/10.1089/dia.2012.0105","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology & Therapeutics","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:2700632","doi":null,"is_oa":true,"landing_page_url":"http://europepmc.org/articles/PMC3698679","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"","raw_type":"Text"},{"id":"pmid:23046400","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23046400","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes technology & therapeutics","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:3698679","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC3698679/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technol Ther","raw_type":"Text"},{"id":"pmh:oai:https://orca.cardiff.ac.uk:42041","doi":null,"is_oa":false,"landing_page_url":"https://orca.cardiff.ac.uk/42041/","pdf_url":null,"source":{"id":"https://openalex.org/S4306401195","display_name":"ORCA Online Research @Cardiff (Cardiff University)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I79510175","host_organization_name":"Cardiff University","host_organization_lineage":["https://openalex.org/I79510175"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"Article"}],"best_oa_location":{"id":"doi:10.1089/dia.2012.0105","doi":"https://doi.org/10.1089/dia.2012.0105","is_oa":true,"landing_page_url":"https://doi.org/10.1089/dia.2012.0105","pdf_url":null,"source":{"id":"https://openalex.org/S67495602","display_name":"Diabetes Technology & Therapeutics","issn_l":"1520-9156","issn":["1520-9156","1557-8593"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-2","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetes Technology & Therapeutics","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320332163","display_name":"U.S. Food and Drug Administration","ror":"https://ror.org/034xvzb47"},{"id":"https://openalex.org/F4320332505","display_name":"U.S. Public Health Service","ror":"https://ror.org/05xf94514"},{"id":"https://openalex.org/F4320334498","display_name":"Sanofi-Aventis Deutschland","ror":"https://ror.org/03ytdtb31"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":26,"referenced_works":["https://openalex.org/W10960370","https://openalex.org/W1424849964","https://openalex.org/W1540299321","https://openalex.org/W1963524859","https://openalex.org/W1963911546","https://openalex.org/W1976262525","https://openalex.org/W1979325667","https://openalex.org/W2004147980","https://openalex.org/W2006512810","https://openalex.org/W2006866083","https://openalex.org/W2013701819","https://openalex.org/W2036987142","https://openalex.org/W2038947914","https://openalex.org/W2048049691","https://openalex.org/W2071095038","https://openalex.org/W2079824131","https://openalex.org/W2080611602","https://openalex.org/W2083817600","https://openalex.org/W2084620925","https://openalex.org/W2086437884","https://openalex.org/W2110270840","https://openalex.org/W2134380349","https://openalex.org/W2142289247","https://openalex.org/W2144355443","https://openalex.org/W2341245113","https://openalex.org/W4212882067"],"related_works":["https://openalex.org/W2059962729","https://openalex.org/W4253976072","https://openalex.org/W2893832102","https://openalex.org/W2018155335","https://openalex.org/W2538372862","https://openalex.org/W2134380349","https://openalex.org/W4408540388","https://openalex.org/W2977865970","https://openalex.org/W4285044185","https://openalex.org/W2512794097"],"abstract_inverted_index":{"Several":[0,142],"biopharmaceuticals,":[1],"including":[2,145],"insulin":[3,5,139,146,176,193,195],"and":[4,29,43,72,89,109,166,187,194,205],"analogs,":[6],"are,":[7],"or":[8],"shortly":[9],"will":[10],"be,":[11],"off-patent,":[12],"thereby":[13],"providing":[14],"an":[15,169],"opportunity":[16],"for":[17,54,64,92,101,130,163,171],"companies":[18],"to":[19,21,26,57],"attempt":[20],"manufacture":[22],"\"copies\"":[23],"commonly":[24],"referred":[25],"as":[27,32,45],"biosimilars":[28],"also":[30],"known":[31],"follow-on":[33],"biologics.":[34],"Reassurance":[35],"that":[36],"such":[37,65],"copy":[38],"biologics":[39,94],"are":[40,151],"equally":[41],"safe":[42],"effective":[44],"the":[46,55,103,180,214],"conventional":[47,136],"products":[48,111,137],"is":[49,52,61],"essential.":[50],"It":[51],"important":[53],"clinician":[56],"consider":[58],"what":[59],"information":[60],"therefore":[62],"necessary":[63],"assurances.":[66],"Biopharmaceuticals,":[67],"produced":[68],"from":[69,81,98],"living":[70],"organisms":[71],"manufactured":[73],"by":[74,140,179,200,209],"complex":[75],"processes,":[76],"differ":[77,96],"in":[78,154,213],"many":[79,155],"respects":[80],"chemically":[82],"derived":[83],"drugs.":[84],"The":[85],"biological":[86],"source":[87],"materials":[88],"manufacturing":[90],"processes":[91],"non-innovator":[93,110,143],"may":[95],"considerably":[97],"those":[99],"used":[100],"producing":[102],"innovator":[104,108],"substance.":[105],"Differences":[106],"between":[107],"can":[112],"be":[113,198],"identified":[114],"analytically":[115],"(e.g.,":[116,138],"batch-to-batch":[117],"consistency,":[118],"product":[119],"stability":[120],"along":[121],"side":[122],"clinical":[123,206],"safety).":[124],"This":[125],"provides":[126],"a":[127,172],"strong":[128],"argument":[129],"caution":[131],"before":[132],"automatic":[133],"substitution":[134],"of":[135,158,185,216],"biosimilars).":[141],"insulins,":[144],"analogs":[147],"(while":[148],"still":[149],"patent-protected),":[150],"already":[152],"available":[153],"countries.":[156],"Many":[157],"these":[159],"lack":[160],"rigorous":[161],"regulations":[162],"biosimilar":[164,173,192],"approval":[165],"pharmacovigilance.":[167],"Recently":[168],"application":[170],"recombinant":[174],"human":[175],"was":[177],"withdrawn":[178],"European":[181],"Medicines":[182],"Agency":[183],"because":[184],"safety":[186],"efficacy":[188],"concerns.":[189],"Therefore,":[190],"every":[191],"analog":[196],"should":[197],"assessed":[199],"well-defined":[201],"globally":[202],"harmonized":[203],"preclinical":[204],"studies":[207],"followed":[208],"post-marketing":[210],"pharmacovigilance":[211],"programs,":[212],"interest":[215],"people":[217],"with":[218],"diabetes":[219],"worldwide.":[220]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":2},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":7},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":9},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":11},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}